Proviron (mesterolone) is not a traditional estrogen blocker like selective estrogen receptor modulators (SERMs) such as tamoxifen or aromatase inhibitors (AIs) such as anastrozole. Instead, Proviron functions as an androgen receptor antagonist and an aromatase inhibitor.
Here's how Proviron affects estrogen levels:
Aromatase Inhibition: Proviron inhibits the aromatase enzyme, which is responsible for converting androgens (like testosterone) into estrogen. By inhibiting aromatase, Proviron can reduce the conversion of testosterone into estrogen, thereby potentially decreasing estrogen levels in the body.
Competitive Binding to Estrogen Receptor: While Proviron itself does not directly bind to estrogen receptors, its metabolites can weakly bind to estrogen receptors. This binding may have some antagonistic effects on estrogen receptors, further contributing to its anti-estrogenic properties.
While Proviron does have some anti-estrogenic properties, it's not typically used as the primary agent for estrogen blockade or management in medical settings. It may be used in conjunction with other medications for such purposes, particularly in the context of testosterone replacement therapy or during anabolic steroid cycles to mitigate estrogen-related side effects like water retention and gynecomastia.
